Shepherd Kaplan Krochuk’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-2,566
Closed -$26K 257
2017
Q3
$26K Sell
2,566
-2,300
-47% -$21.2K 0.02% 214
2017
Q2
$50K Sell
4,866
-7,896
-62% -$99.6K 0.03% 226
2017
Q1
$179K Sell
12,762
-950
-7% -$14.5K 0.09% 170
2016
Q4
$207K Sell
13,712
-18,203
-57% -$276K 0.06% 166
2016
Q3
$517K Sell
31,915
-300
-0.9% -$4.94K 0.11% 131
2016
Q2
$512K Buy
32,215
+24,240
+304% +$428K 0.13% 108
2016
Q1
$202K Buy
+7,975
New +$245K 0.06% 203
2015
Q4
Sell
-4,200
Closed -$157K 395
2015
Q3
$148K Buy
+4,200
New +$189K 0.04% 305

Other funds holding HHS

Shepherd Kaplan Krochuk's HHS Position: Q4 2017 in Review

Shepherd Kaplan Krochuk sold out of Harte-Hanks (HHS) in Q4 2017, closing a stake of 2,566 shares — an estimated $26K sold.

Shepherd Kaplan Krochuk first reported a position in HHS in Q3 2015 and held it in 8 quarters. The position peaked at $517K in Q3 2016. 48 funds tracked by Wall St. Rank hold HHS as of Q4 2017.

  • Shepherd Kaplan Krochuk reported no remaining Harte-Hanks position as of Q4 2017 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 2,566 Harte-Hanks shares in Q4 2017, an estimated $26K.
  • Shepherd Kaplan Krochuk first reported a position in Harte-Hanks in Q3 2015 and held it in 8 quarters.
  • Shepherd Kaplan Krochuk's Harte-Hanks position peaked at $517K in Q3 2016.
  • 48 funds tracked by Wall St. Rank held Harte-Hanks as of Q4 2017.

Based on Shepherd Kaplan Krochuk's 13F filing for Q4 2017, filed 13 Feb 2018.